Skip to content
MedsAcross

Fixed-dose combination

Penicillin g benzathine and Penicillin g procaine

Also known as penicillin g benzathine, penicillin g procaine
Available on requestCold chain
Presentations
2
Brands
2
Manufacturers
1
Available from stock
0

Penicillin g benzathine and Penicillin g procaine is a fixed-dose combination medicine. It is available as injectable suspension for intramuscular use. MedsAcross supplies Penicillin g benzathine and Penicillin g procaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Penicillin-class Antibacterial
US FDA first approval
18 May 1953
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Intramuscular
Dosage forms
Injectable suspension
Fixed-dose combination of
Penicillin g benzathine, Penicillin g procaine

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bicillin C-R and other antibacterial drugs, Bicillin C-R should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. This drug is indicated in the treatment of moderately severe infections due to penicillin-G-susceptible microorganisms that are susceptible to serum levels common to this particular dosage form. Therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response.

Source: US FDA prescribing information

How it works

Penicillin G exerts a bactericidal action against penicillin-susceptible microorganisms during the stage of active multiplication. It acts through the inhibition of biosynthesis of cell-wall peptidoglycan, rendering the cell wall osmotically unstable resulting in death of the bacterium. Resistance Penicillin is not active against penicillinase-producing bacteria, or against organisms resistant to beta-lactams because of alterations in the penicillin-binding proteins. Resistance to penicillin G has not been reported in Streptococcus pyogenes. Penicillin has been shown to be active against most isolates of the following bacteria, both in vitro and in clinical infections as described in the INDICATIONS AND USAGE section. Gram-positive bacteria Beta-hemolytic streptococci (groups A, B, C, G, H, L and M). Streptococcus pneumoniae (penicillin-susceptible isolates only).

Source: US FDA prescribing information

Dosing overview

Streptococcal Infections Group A Infections of the upper-respiratory tract, skin and soft-tissue infections, scarlet fever, and erysipelas. The following doses are recommended: Adults and pediatric patients over 60 lbs. in weight: 2,400,000 units. Pediatric patients from 30 to 60 lbs.: 900,000 units to 1,200,000 units. Pediatric patients under 30 lbs.: 600,000 units. NOTE: Treatment with the recommended dosage is usually given at a single session using multiple IM sites when indicated. An alternative dosage schedule may be used, giving one-half (1/2) the total dose on day 1 and one-half (1/2) on day 3. This will also insure the penicillinemia required over a 10-day period, however, this alternate schedule should be used only when the physician can be assured of the patient's cooperation.

Source: US FDA prescribing information

Warnings and precautions

Boxed warning: Prior to administration of this drug, carefully read the WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION sections of the labeling. Boxed warning: Prior to administration of this drug, carefully read the WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION sections of the labeling. The combination of penicillin G benzathine and penicillin G procaine should only be prescribed for the indications listed in this insert. Anaphylaxis SERIOUS AND OCCASIONALLY FATAL HYPERSENSITIVITY (ANAPHYLACTIC) REACTIONS HAVE BEEN REPORTED IN PATIENTS ON PENICILLIN THERAPY. THESE REACTIONS ARE MORE LIKELY TO OCCUR IN INDIVIDUALS WITH A HISTORY OF PENICILLIN HYPERSENSITIVITY AND/OR A HISTORY OF SENSITIVITY TO MULTIPLE ALLERGENS.

Source: US FDA prescribing information

Side effects

As with other penicillins, untoward reactions of the sensitivity phenomena are likely to occur, particularly in individuals who have previously demonstrated hypersensitivity to penicillins or in those with a history of allergy, asthma, hay fever, or urticaria.

Source: US FDA prescribing information

Interactions

Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin, and concurrent use of these drugs should be avoided. Concurrent administration of penicillin and probenecid increases and prolongs serum penicillin levels by decreasing the apparent volume of distribution and slowing the rate of excretion by competitively inhibiting renal tubular secretion of penicillin.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

2 presentations of Penicillin g benzathine and Penicillin g procaine, sorted by availability.

MedicineActive ingredientManufacturerRegisterAvailability
Bicillin CR 600000 IU/600000 IU per 2 mL injectable suspensionIntramuscular Cold chainPenicillin g benzathine and Penicillin g procainePfizer LaboratoriesUS FDAAvailable on request
Bicillin C-R 900/300 900000 IU/300000 IU per 2 mL injectable suspensionIntramuscular Cold chainPenicillin g benzathine and Penicillin g procainePfizer LaboratoriesUS FDAAvailable on request

Brands by market

2 brand names across 1 markets.

Brand names by country

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 18 May 1953Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Penicillin g benzathine and Penicillin g procaine available for export from India?

Yes, on request. MedsAcross lists 2 presentations of Penicillin g benzathine and Penicillin g procaine and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Penicillin g benzathine and Penicillin g procaine have?

The catalogue lists 2 brand names for Penicillin g benzathine and Penicillin g procaine, including Bicillin C-R 900/300, Bicillin CR.

Is Penicillin g benzathine and Penicillin g procaine approved by the US FDA?

Yes. The US FDA first approved Penicillin g benzathine and Penicillin g procaine on 18 May 1953, according to Drugs@FDA.

Does Penicillin g benzathine and Penicillin g procaine need cold chain shipping?

At least one listed presentation of Penicillin g benzathine and Penicillin g procaine must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.

References

  1. BICILLIN CR prescribing information (Pfizer Laboratories). U.S. National Library of Medicine, DailyMed. Retrieved 21 July 2026

Request Penicillin g benzathine and Penicillin g procaine for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.